Table 2.
Ref.
|
Treatment
|
Dose and duration
|
Parameters analyzed
|
Conclusion
|
Agraib et al[43], 2022 | Lactobacillus and Bifidobacterium species | 3 × 1010 probiotic capsules | Partial mayo score, CRP, IgA, IL-10, hemoglobin, hematocrit, and RBC levels | Significantly induced remission in UC patients |
Ojetti et al[44], 2022 | Limosilactobacillus reuteri ATCC PTA 4659 | Two times a day for 10 d | Inflammatory markers CRP and calprotectin | Significantly reduced both blood and fecal inflammatory marker |
Wu et al[45], 2021 | Live bacillus licheniformis capsules and live combined Bifidobacterium, lactobacillus, and enterococcus capsules followed by Chamomile capsules | Bacillus licheniformis capsules two capsules, three times a day and live combined Bifidobacterium, lactobacillus, and enterococcus capsules two capsules twice a day. Probiotics consumed at a level of 107 CFU/mL | Leiden Index of Depression Sensitivity, Beck Depression Inventory questionnaires | Probiotics tend to improve cognitive reactivity to the sad mood in CD patients |
Bamola et al[46], 2021 | Bacillus coagulans Unique IS-2 | 2 billion-CFU/capsule twice in day 4 wk | Presence of beneficial gut bacteria, serum cytokines, symptoms of the disease | Showed beneficial effect when administered along with standard medical treatment |
Waal M van der et al[47], 2019 | Nine bacterial strains (Bifidobacterium bifidum W23; Bifidobacterium lactis W51; Bifidobacterium lactis W52; Lactobacillus acidophilus W22; Lactobacillus casei W56; Lactobacillus paracasei W20; Lactobacillus plantarum W62; Lactobacillus salivarius W24; Lactobacillus lactis W19) | 7.5 × 109 CFU per 3 g in powder form, once daily for 6 wk | Quality of life from a patient perspective (semi-structured interviews) | Effective |
Kamarli Altun et al[48], 2022 | Enterococcus faecium, Lactobacillus Plantarum, Streptococcus thermophilus, Bifidobacterium lactis, Lactobacillus acidophilus, Bifidobacterium long, and FOS | Probiotic strains (3 × 109 CFU) and FOS (225 mg/ tablet), 1 tablet twice a day for 8 wk | Hemoglobin, leukocyte, neutrophil-to-lymphocyte ratio, sedimentation, and CRP, clinical and endoscopic activity indices | Effective |
Sun et al[49], 2018 | Clostridium butyricum | 420 mg per capsule, 1.5 × 107 CFU/g, 3 capsules 3 times a day for 4 wk | Change from baseline in IBD symptoms, quality of life, stool consistency, and frequency | Effective |
Matsuoka et al[50], 2018 | Bifidobacterium breve strain Yakult and Lactobacillus acidophilus | 10 billion bacteria of Bifidobacterium breve and 1 billion bacteria of Lactobacillus acidophilus, one pack per day for 48 wk | Clinical procedure (change in abdominal symptom score from baseline. Sutherland DAI subscore, change in abdominal symptom scores (passage of flatus and bloating), and intestinal microbiota | Less significant effect |
CRP: C-reactive protein; UC: Ulcerative colitis; CD: Crohn’s disease; CFU: Colony forming unit; FOS: Fructooligosaccharides; DAI: Disease activity index; IBD: Inflammatory bowel disease; IgA: Immunoglobulin A; RBC: Red blood cell; IL: Interleukin.